{"trigger": ["Epstein-Barr virus binding to <extra_id_0> CD21 <extra_id_2> Protein <extra_id_1> activates the initial viral promoter via NF-kappaB induction .", "Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappaB induction ."], "relation": []}
{"trigger": ["Epstein-Barr virus ( EBV ) , an oncogenic human herpesvirus , binds to and infects normal human B lymphocytes via <extra_id_0> CD21 <extra_id_2> Protein <extra_id_1> , the <extra_id_0> CR2 <extra_id_2> Protein <extra_id_1> complement receptor .", "Epstein-Barr virus ( EBV ) , an oncogenic human herpesvirus , binds to and infects normal human B lymphocytes via CD21 , the CR2 complement receptor ."], "relation": []}
{"trigger": ["Studies of the mechanisms that enable EBV to infect nonactivated , noncycling B cells provide compelling evidence for a sequence of events in which EBV binding to <extra_id_0> CD21 <extra_id_2> Protein <extra_id_1> on purified resting human B cells rapidly activates the NF-kappaB transcription factor , which , in turn , binds to and mediates transcriptional activation of Wp , the initial viral latent gene promoter .", "Studies of the mechanisms that enable EBV to infect nonactivated , noncycling B cells provide compelling evidence for a sequence of events in which EBV binding to CD21 on purified resting human B cells rapidly activates the NF-kappaB transcription factor , which , in turn , binds to and mediates transcriptional activation of Wp , the initial viral latent gene promoter ."], "relation": []}
{"trigger": ["Thus , EBV binding to its cellular receptor on resting B cells triggers an NF-kappaB - dependent intracellular signaling pathway which is required for infection .", "Thus , EBV binding to its cellular receptor on resting B cells triggers an NF-kappaB - dependent intracellular signaling pathway which is required for infection ."], "relation": []}
